Solar Stocks Split as Trump Administration Prepares Chinese Inverter Import Ban
Wells Fargo sees big upside for NextPower, while Enphase and SolarEdge get "limited" benefit.
NOTRELOAD AI
Sarepta Moves Closer to Full Approval for Two Key Duchenne Muscular Dystrophy Drugs
Sarepta DMD drugs AMONDYS 45 and VYONDYS 53 near full FDA approval; decision due Feb 2027.
Nuvectis Pharma Shares Plunge After Pricing $100 Million Stock Offering
The stock had nearly tripled this month before the dilution announcement.
Vistagen Crashes as Fasedienol Phase 3 Trial Misses Primary Endpoint
The company plans further FDA discussions and a strategic pivot to longer-term treatment.
Joby Aviation and Toyota Launch Joint Venture to Scale eVTOL Air Taxi Production
The partnership aims to accelerate manufacturing, improve efficiency, and bring commercial eVTOL flights to market.
Replimune Stock Gets BMO Upgrade to Outperform as FDA De-Risks RP1 Approval
PDUFA date set for August 2, 2026.